Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-month Prospective Observational Study Assessing the Real-world Clinical Effectiveness, Safety and Health-economic Benefits of Toujeo® Initiation After Oral Antidiabetic Drug Failure in Insulin-naïve Patients With Type 2 Diabetes Mellitus

NCT03703869 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03703869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03703869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-month Prospective Observational Study Assessing the Real-world Clinical Effectiveness, Safety and Health-economic Benefits of Toujeo® Initiation After Oral Antidiabetic Drug Failure in Insulin-naïve Patients With Type 2 Diabetes Mellitus
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
March 6, 2018
Completion date
February 24, 2020
Enrollment
4,589 (actual)
Sites
388

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes